PPT-Primer on Kinase Inhibitors

Author : giovanna-bartolotta | Published Date : 2018-11-03

Richard R Furman Directory CLL Research Center Weill Cornell Medical College New York Presbyterian Hospital BCRassociated Kinases Proven Effective Therapeutic Targets

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Primer on Kinase Inhibitors" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Primer on Kinase Inhibitors: Transcript

Richard R Furman Directory CLL Research Center Weill Cornell Medical College New York Presbyterian Hospital BCRassociated Kinases Proven Effective Therapeutic Targets Nat Rev Immunol 2945. From molecular biology to Clinical Trials. Paolo M. Comoglio, MD. Institute for Cancer Research @ Candiolo,. University of Turin, Medical School, Italy . MET . IS A ‘MASTER GENE’ . IN THE CONTROL OF INVASIVE GROWTH. Kinase. Inhibitors. Charles Harrell. Outline of Material Presented. Definition of Cancer. Understanding . Kinases. Kinase. Inhibitor Functionality. Economic Considerations. Assigned Reading. Homework Questions. 322 BCH. Exp. (8). In this experiment, we will continue to study . acid phosphatase . kinetics.. Objectives. To . study the effect of inhibitors on the rate of an enzymatic reaction.. To . determine the type of inhibition of acid phosphatase by inorganic phosphate and sodium fluoride. . . . University of Witwatersrand. Dr Nathan October. Kinections. Map P36507. MEK2/MAP2K2. P36507. -T230. -S216. +S226. +S222. B-. Raf. P15056. COT/MAP3K8. P41279. PDK1/PDPK1. O15530. MORG1. Q9BRX9. SGK1. O00141. BMAL1. O00327. T484. KRT8. P05787. S74. Kinections. Map P52564. PKR/EIF2AK2. P19525. DCTN1. Q14203. MKK6/MAP2K6. P52564. -Y219. +T211. +S207. MEKK1/MAP3K1. Q13233. COT/MAP3K8. P41279. ASK1/MAP3K5. Q99683. MEKK2/MAP3K2. Q9Y2U5. MEKK3/MAP3K3. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data Faculty Javier Cortes, MD, PhD Head Breast Cancer Program Oncology Department Ramon y Cajal University Hospital Madrid, Spain 1 | 7:39998 | DOI: 10.1038/srep39998 www.nature.com/scientificreports 2 domain and the GDI-like domain sandwich actin, triggering YopO autophosphorylation and the allosteric stabilization of the acti 322 BCH. Exp. (8). In this experiment, we will continue to study . acid phosphatase . kinetics.. Objectives. To . study the effect of inhibitors on the rate of an enzymatic reaction.. To . determine the type of inhibition of acid phosphatase by inorganic phosphate and sodium fluoride. . Wijesinghe. et. al. 2014.. Presentation by . Jeetika. . Sainani. Wound Healing: A process we experience quite frequently, but rarely understand. What is this process? Why does it matter?. Four stages of wound healing. McInnes, C.; Mezna, M.; Fisher, P. M. Progress in the Discovery of Polo-like Kinase Inhibitors. Curr. Top Med. Chem.2005, 181-197 (a) Katayama, H.; Brinkley, W. R.; Sen, S. The Aurora kinases: Role Antonella Tosti, MD. Miller School of Medicine, University of Miami. Miami, USA. Key messages. There are new treatments coming through for alopecia areata.. JAK inhibitors are at the forefront with three agents available now, and a further seven in development.. “old” chemosensitizers, “new” immune-sensitizers. Martina Godel. SIC Conference – Virtual Event. 27. th. -28. th. October 2021. 1. P-. glycoprotein. and . resistance. to . chemotherapy.

Download Document

Here is the link to download the presentation.
"Primer on Kinase Inhibitors"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.